The 50 portfolio companies in the FTSE 100 Halma group operate in highly regulated niches across the medical, safety and environmental sectors. Their cutting-edge technologies save lives and solve some of the key problems we face in the world.
Halma’s growth strategy depends on the companies’ ability to develop new technologies and offers for their customers, and to explore solutions with the potential to disrupt their existing business models. Our founder-led companies are in turn reliant on legal advisors who understand their technology, tailor their guidance to their size and deliver fast support that allows them to achieve their growth ambitions.